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Murine gammaherpesvirus is a natural rodent pathogen which causes a primary infection in the lungs and
establishes a persistent infection in B lymphocytes. During the primary infection, large amounts of gamma
interferon (IFN-g) are produced by spleen, mediastinal, and cervical lymph node cells. To investigate the role
of IFN-g in control of the virus infection, mice lacking the cellular receptor for IFN-g (IFN-g R2/2 mice) were
infected with murine gammaherpesvirus 68 (MHV68). IFN-g R2/2 mice showed no difference from wild-type
mice in the titers of infectious virus in the lungs or in the rate of clearance of the lung infection. In the spleen,
however, clear differences were observed. By 14 days postinfection, spleens from IFN-g R2/2 mice were pale,
shrunken, and fibrous. Histological examination showed that there was an early (day 10) infiltration of
granulocytes followed by widespread destruction of splenic architecture (days 14 to 17). A marked decrease in
the number of splenic B cells and CD41 and CD81 T cells occurred. These changes were accompanied by a 10-
to 100-fold greater load of latently infected cells in IFN-g R2/2 mice than in wild-type mice at 14 to 17 days
postinfection, but this was reduced to the levels found in wild-type mice by 21 days postinfection. Treatment
of the mice with the antiviral drug 2*-deoxyl-5-ethyl-beta-4*-thiouridine from 6 days postinfection did not
prevent the occurrence of these changes. The changes were, however, completely reversed by depletion of CD81
T cells prior to and during the primary infection. Depletion of CD41 T cells also reversed the major
pathological and virological changes, although in this case there was evidence of some histological changes.
Thus, the lack of IFN-g receptor had profound consequences in spleens of MHV68-infected mice. The possible
mechanisms involved in these changes are discussed.
Murine gammaherpesvirus 68 (MHV68) is a type 2 gamma-
herpesvirus which was isolated from a free-living murid rodent
(2) and which can be readily studied in laboratory mice. As
such, it provides a useful model for the study of a gammaher-
pesvirus in its natural host. After intranasal inoculation, the
virus establishes a productive infection in the lungs, which is
cleared in 7 to 10 days. Replicating virus can be detected in
other tissues, including the spleen, adrenal glands, the heart,
and the kidney, for up to 15 days after infection, but thereafter
no infectious virus can be detected (20). The virus causes a
transient marked splenomegaly apparent 12 to 14 days after
infection and establishes a latent infection in B lymphocytes
(21). Latent virus can also be detected in lung tissue long after
clearance of infectious virus (24).
Clearance of infectious virus from the lung is dependent on
the presence of CD81 T cells (8), and there is evidence for a
role of CD81 T cells in the control of latently infected B cells
in the spleen (14). CD41 T cells also play a pivotal role in
control of infection. CD41 T cell depleted animals show a
slightly delayed clearance of lung infection (23). However,
MHV68-infected major histocompatibility complex (MHC)
class II 2/2 mice which lack CD41 T cells initially clear the
lung infection, but it recurs at around 30 days postinfection and
the animals eventually succumb to the virus infection (4).
CD41 T cells are essential for the development of splenomeg-
aly and for the generation of high numbers of latently infected
cells, which are found at this stage of infection (4, 23). In the
absence of CD41 T cells, the total number of latently infected
cells does not reach the levels found in immunocompetent
mice; however, over a 130-day period CD4-deficient mice have
higher numbers of latently infected cells in spleen, mediastinal
lymph nodes, and cervical lymph nodes than wild-type infected
mice (4).
Cells from the spleens and lymph nodes draining the lungs of
MHV68-infected mice have been shown to produce high levels
of interleukin 6 (IL-6) and gamma interferon (IFN-g) and
lower levels of IL-2 and IL-10 (17). CD41 T-cell deficient, class
II 2/2 mice produce significantly lower levels of IFN-g than
wild-type MHV68-infected mice, implicating IFN-g as a major
player in the CD41 T-cell-mediated control of MHV68 infec-
tion (4). Numerous reports indicate that IFN-g plays an im-
portant role in the control of other herpesvirus infections (3,
10, 12, 18, 19). In order to define the apparent role of IFN-g in
the control of MHV68 infection, we have utilized the gene
knockout IFN-g receptor-negative (IFN-g R2/2) mouse
strain (11). These mice lack the a chain of the IFN-g receptor
and hence the ability to respond to IFN-g, although they retain
the ability to produce IFN-g. Our results indicate that IFN-g is
not important in the clearance of the initial lung infection or in
the long-term surveillance in the lungs, but the lack of IFN-g
receptor has major implications for the maintenance of normal
splenic architecture and plays a major role in the control of the
infection in the spleen.
MATERIALS AND METHODS
Mice. Wild-type 129/Sv/Ev mice and IFN-g R2/2 129/Sv/Ev mice (11) were
purchased from Bantin and Kingman and bred in-house.
* Corresponding author. Phone: (44) 131 650 6169. Fax: (44) 131
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Virus and cells. Virus working stocks were prepared by infection of BHK-21
cells with MHV68 clone G2.4 (2, 7) at low multiplicity (0.1 PFU/cell) as previ-
ously described (20).
Infection and sampling. Age- and sex-matched mice were anesthetized with
Halogen (Rhone Merieux Ltd., Harlow, Essex, United Kingdom) and inoculated
intranasally with 4 3 105 PFU of MHV68 in 40 ml of sterile phosphate-buffered
saline. At various times after infection, mice were killed by cervical dislocation
and tissues were harvested for virus assays or histology.
Virus assays. Virus stocks were assayed on BHK-21 cell monolayers as pre-
viously described (20). For determination of virus titers in tissues, the tissues
were frozen at 270°C, thawed and homogenized, and then frozen again at
270°C. After thawing, the homogenates were centrifuged to remove particulate
matter and titers were determined on BHK-21 monolayers as described for virus
stocks. For detection of latent virus, an infective center assay was carried out.
Spleen cell suspensions were prepared by teasing cells out of the capsule, eryth-
rocytes were lysed by brief resuspension in water, and the lymphocytes were
cocultivated with BHK-21 cells for 5 days. Cell monolayers were fixed and
stained with toluidine blue, and the numbers of splenocytes giving rise to plaques
were determined. For detection of infectious virus in splenocytes, single-cell
suspensions, prepared as for the infective-center assays, were either frozen at
270°C or disrupted by sonication, clarified by centrifugation, and assayed on
BHK-21 monolayers.
Flow cytometry. Splenic lymphocytes were stained with monoclonal antibodies
directed against B220 (RA3-6B2; Pharmingen), CD4 (YTS177.9.6.1), or CD8
(YTS105.18.10) as previously described (8). Stained cells were analyzed on a
FACScan flow cytometer (Becton Dickinson).
In vivo inhibition of virus replication. At six days postinfection, mice were
injected with 1 mg of 29-deoxyl-5-ethyl-beta-49-thiouridine (49-S-EtdU) (21a) in
water and thereafter supplied ad libitum with drinking water containing 0.33 mg
of drug per ml.
Depletion of CD41 and CD81 T cells. Rat immunoglobulin G2b monoclonal
antibodies YTS 191.1 (anti-CD4) and YTS 169.4 (anti-CD8) were used for
depletion of lymphocyte subsets as previously described (6, 8). Briefly, the anti-
bodies were injected intravenously 2 days prior to infection and 2 days postin-
fection and then at weekly intervals intraperitoneally.
Histopathological studies. Portions of spleen were fixed in buffered Formol
saline, processed routinely to 5-mm paraffin wax-embedded sections, stained with
hematoxylin and eosin, and examined by light microscopy.
RESULTS
Replication of MHV68 in the lungs of IFN-g R2/2 mice.
Wild-type 129/Sv/Ev mice and IFN-g R2/2 mice were infected
intranasally with 4 3 105 PFU of MHV68. The lungs were
examined for the presence of infectious virus at various times
after infection. Figure 1 shows the titers of infectious virus in
the lungs of wild-type and IFN-g R2/2 mice. No difference in
the rates of clearance of virus from the lungs of the two groups
of animals was observed.
Effect of MHV68 infection on spleen cell populations and
splenic architecture. Early after MHV68 infection, it was clear
that there were major differences in the effects of virus infec-
tion on the spleens of wild-type and IFN-g R2/2 mice. On day
14 postinfection, it was noted that the spleens of the IFN-g
R2/2 mice were pale and shrunken, and these changes be-
came more pronounced as the infection progressed (Fig. 2).
The effect of MHV68 infection on the splenic architecture in
wild-type and IFN-g R2/2 mice was examined histologically.
From day 10 postinfection, spleens from wild-type mice
showed moderate white pulp hyperplasia. Follicles, periarte-
riolar areas, and marginal zones showed increased cellularity
and expansion. Lymphoblasts and mitotic figures were appar-
ent in these regions, and there were also scattered foci of
apoptotic bodies and nuclear debris. Red pulp areas were
largely unaffected except for some mild hyperplasia of splenic
cords (Fig. 3a). By day 21 postinfection, white pulp hyperplasia
was less pronounced, and thereafter there were decreasing
signs of activation in the spleen (Fig. 3b). The IFN-g R2/2
spleens showed some white pulp hyperplasia at day 10 postin-
fection, but by day 14 and beyond, changes were distinctly
different. There was a marked, diffuse and focal infiltrate of
granulocytes into the white pulp areas, especially the periarte-
riolar sheath (Fig. 3c). By day 17 postinfection, early fibropla-
sia with plump fibroblasts and collagenous matrix deposition in
peripheral white pulp and all red pulp areas was obvious. By
day 21 postinfection, lesions consisted of substantial areas of
more mature fibrosis admixed with fewer granulocytes and
splenic cord cells. These lesions dominated the splenic tissue
and surrounded multiple, small focal aggregates of surviving
B-cell areas of white pulp. In one sample at day 31 there were
focal areas of bony metaplasia within the fibrotic areas (Fig.
3d). The virus-induced histological changes progressed no fur-
ther after day 21 but, unlike the findings for the wild-type
spleens, the changes were not reversible.
The decreased cellularity in the infected IFN-g R2/2
spleens was reflected in the numbers of cells recovered from
these spleens. Figure 4 shows the total numbers of splenocytes
(panel a) and the numbers of cells in each of the three major
lymphocyte subsets (panel b) in the spleens of wild-type and
IFN-g R2/2 mice at various times after infection. Whereas
the spleens of wild-type mice developed splenomegaly and
showed a twofold increase in cell numbers characteristic of
MHV68 infection (14), there was a rapid fall in the number of
cells in the spleens of IFN-g R2/2 mice such that by 21 days
postinfection there were more than 10-fold fewer cells in the
FIG. 1. MHV68 replication in the lungs of wild-type 129/Sv/Ev and IFN-g
R2/2 mice. Mice were inoculated with 4 3 105 PFU of virus intranasally. Mean
virus titer/lung 6 standard deviation for four mice/group is shown for each time
point. n, wild type; {, IFN-g R2/2. The limit of detection was 10 PFU/lung.
FIG. 2. Spleens from MHV68-infected wild-type and IFN-g R2/2 mice 17
days postinfection. WT, wild type; gKO, IFN-g R2/2.
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spleens of these mice. Figure 4b shows that the decrease in cell
number was not confined to a particular cell subset but oc-
curred in B-cell and CD41 and CD81 T-cell subsets.
MHV68 latent infection in the spleens of IFN-g R2/2 mice.
The number of latently infected cells in the spleens of MHV68-
infected wild-type and IFN-g R2/2 mice was investigated by
an infective-center assay. Spleens were also assayed for the
presence of infectious virus. In no case did we detect infectious
virus in wild-type spleens. In the case of IFN-g R2/2 spleens,
low levels of infectious virus were detected (,50 PFU/107
cells). Similar titers of virus were obtained when the spleno-
cytes were lysed by freeze-thawing or by sonication (data not
shown). Figure 5 shows the number of infective centers per 107
cells in wild-type and IFN-g R2/2 spleens corrected for the
infectious virus titers present in the IFN-g R2/2 spleens.
Although the total number of B cells in the IFN-g R2/2
spleens decreased, the latency load (number of latently in-
fected cells/107 splenocytes) was clearly higher in the spleens of
IFN-g R2/2 mice than in wild-type mice. As has been shown
for other mouse strains (14), the number of latently infected
spleen cells in wild-type mice reached a peak around day 14 but
in the third week declined to a relatively stable level of around
1 in 106 spleen leukocytes. The number of infective centers per
107 cells in IFN-g R2/2 spleens reached 10- to 100-fold higher
levels than were seen in wild-type spleens. However, the infec-
tive center load in IFN-g R2/2 spleens did not remain high
but declined to around 1 in 106 splenocytes by the end of the
fourth week after infection.
Role of infectious virus in pathological changes. The pres-
ence of low levels of MHV68 in the spleens of IFN-g R2/2
mice suggested that the pathological changes were unlikely to
be attributed to virus-mediated cell destruction or damage. To
investigate this more fully, we treated wild-type and IFN-g
R2/2 mice with the antiviral drug 49-S-EtdU from 6 days
postinfection. Treatment with this drug completely inhibits
virus replication within 24 h (21a). Day 6 was chosen because
previous work has shown that treatment from this time does
not alter the time course of spleen infection. Peak levels of
latently infected cells and splenomegaly occur at the same time
as in untreated mice (1). At 15 days postinfection, spleen cell
numbers were determined and splenocytes were assayed for
the presence of infective centers and infectious virus. No in-
fectious virus could be detected in either IFN-g R2/2 or wild
type-spleens. Table 1 shows that treatment with the drug did
not prevent the decrease in spleen cell numbers or the devel-
opment of an increased load of latently infected cells in
MHV68-infected IFN-g R2/2 mice. 49-S-EtdU-treated mice
show levels of infective centers similar to those found in un-
treated mice. These levels were fivefold higher than those
found in wild-type mice. The cellular destruction and increased
latency load could not therefore be attributed to virus infection
of splenocytes followed by lysis of infected cells but is more
FIG. 3. Histopathology of wild-type 129/Sv/Ev and IFN-g R2/2 spleens after MHV68 infection. Hematoxylin and eosin stain; objective magnifications are in
parentheses. (a) Wild-type spleen 14 days postinfection showing white pulp hyperplasia and nonreactive red pulp (37); (b) wild-type spleen 31 days postinfection
showing less-prominent white pulp hyperplasia with nonreactive red pulp (314); (c) IFN-g R2/2 spleen 14 days postinfection showing follicular lymphoid area
surrounded by sheets of mononuclear cells and infiltrating neutrophil polymorphs and fibrotic areas; red pulp areas are involved in the reaction (37); (d) IFN-g R2/2
spleen, day 31 postinfection; splenic parenchyma is dominated by areas of mature fibrosis with mononuclear inflammatory cells; there are also focal areas of bony
metaplasia in this sample (314). R, red pulp; W, white pulp; B, bony metaplasia; closed arrow, follicular lymphoid area; open arrow, area containing infiltrating
polymorphs and fibrosis.
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likely to be due to perturbation of the mechanisms controlling
latency.
The role of CD81 and CD41 T cells in MHV68 infection of
IFN-g R2/2 mice. In order to investigate whether immuno-
pathology was contributing to the splenic destruction observed
in IFN-g R2/2 mice infected with MHV68, we removed the
CD81 and CD41 T-cell subsets by treating the mice anti-CD4
and anti-CD8 monoclonal antibodies. Mice were injected with
anti-CD8 or -CD4 antibodies 2 days prior to infection and 2
and 9 days postinfection. At 16 days postinfection, spleens
were harvested and weighed. Half of each spleen was fixed and
stained for histological examination, and the other half was
used to determined cell number, infective-center load, and
infectious virus titer. CD81 and CD41 T-cell depletions were
monitored by staining with anti-CD4 and anti-CD8 antibodies
and analyzing by FACScan. In all cases, the antibody treatment
removed .95% of the relevant T-cell subset.
Table 2 shows the results of infection of CD81 T-cell-de-
pleted and nondepleted wild-type and IFN-g R2/2 mice. Re-
moval of CD81 cells from the IFN-g R2/2 mice substantially
abrogated the changes seen in the nondepleted mice. Spleens
from the IFN-g R2/2 CD81 T-cell-depleted mice were sim-
ilar in gross appearance and weight to wild-type CD81 T-cell-
depleted or untreated spleens. Histological examination con-
firmed that these spleens, like the wild-type spleens, showed
mild white pulp hyperplasia with no obvious fibrosis and only a
few infiltrating granulocytes. CD81 T-cell-depleted, MHV68-
infected IFN-g R2/2 spleens developed splenomegaly, and
the infective-center load was not significantly different from
that seen in wild-type mice (Table 2). These results showed
quite clearly that the pathological and histological changes
seen in MHV68-infected IFN-g R2/2 mice were mediated by
CD81 T cells.
Table 2 also shows the results of a similar experiment in
which CD41 T cells had been depleted. Removal of CD41 T
cells reversed the changes in spleen appearance and the weight
and cell loss seen in nondepleted IFN-g R2/2 mice infected
with MHV68 and reduced the number of infective centers to
levels found in untreated wild-type mice. As previously ob-
served, the development of splenomegaly was dependent on
the presence of CD41 T cells, and lower numbers of infective
centers were found in CD41 T-cell-depleted wild-type mice (4,
23). However, histological examination showed that a mild to
moderate granulocytic infiltration and fibroplasia had occurred
in the interfollicular areas of the white pulp. Thus, some patho-
logical changes were occurring in the absence of CD41 T cells.
DISCUSSION
Clearance of MHV68 from the lungs of infected mice is
dependent on the presence of CD81 T cells and to some extent
on that of CD41 T cells (8, 14). Both these cell types are potent
producers of IFN-g. IFN-g has a dual role in interfering with
FIG. 4. Spleen cell numbers following MHV68 infection of wild-type 129/
Sv/Ev and IFN-g R2/2 mice. Mice were inoculated with 4 3 105 PFU of virus
intranasally. (a) Total number of splenocytes. Mean cell number 6 standard
deviation for four mice/group is shown for each time point. {, wild type; },
IFN-g R2/2. (b) Total number of B cells (B2201), CD41 T cells, and CD81 T
cells. Numbers for four mice were determined for each time point. h, wild-type
B cells; E, wild-type CD41 T cells; {, wild-type CD81 T cells; n, IFN-g R2/2
B cells; F, IFN-g R2/2 CD41 T cells; }, IFN-g R2/2 CD81 T cells.
FIG. 5. Infective centers in the spleens of wild-type 129/Sv/Ev and IFN-g
R2/2 mice. Mice were inoculated with 4 3 105 PFU of virus intranasally. Mean
infective-center numbers 6 standard deviations for four mice/group are shown
for each time point. Results are expressed as infective centers/107 splenic leu-
kocytes. Infectious virus titers (50 PFU/spleen) have been subtracted from the
infective-center numbers. n, wild type; F, IFN-g R2/2.
TABLE 1. Effect of inhibition of virus replication on MHV68-




No. of infective centers/
107 cells (SD)
Wild type 14.5 (2.4) 200 (146)
Wild type, 49-S-EtdU treated 18.8 (2.6) 355 (105)
IFN-g R2/2 5.6 (1.1) 1,613 (333)
IFN-g R2/2, 49-S-EtdU
treated
8.0 (2.3) 1,200 (492)
a Mice were injected intraperitoneally with 1 mg of the antiviral drug 49-S-
EtdU 6 days postinfection and thereafter supplied ad libitum with drinking water
containing 0.33 mg of drug per ml. Spleens were harvested 15 days postinfection.
VOL. 71, 1997 MHV68 INFECTION IN IFN-g RECEPTOR-DEFICIENT MICE 4281
virus infections: it acts directly to induce an antiviral state
within the infected cell, and it acts indirectly by upregulating
the activity of the immune system (reviewed in reference 1a).
The data presented here show that there is no difference in the
amount of replication of MHV68 as measured by virus titer or
in the rate of clearance of infectious virus from the lungs
between wild-type and IFN-g R2/2 mice. This suggests that
IFN-g does not have a direct effect on virus replication and is
not involved in the process by which CD81 T cells clear
MHV68 from the lungs (8).
In contrast to the apparent lack of a role for IFN-g in the
lungs of IFN-g R2/2 MHV68-infected mice, there are pro-
found effects on splenic architecture and on the process of
establishment of latency in the spleens of these mice. Early in
the second week after infection, large numbers of granulocytes
are observed in the spleen. It is not clear what causes this
infiltration, and the role of granulocytes in the subsequent
pathological changes in the spleen is at present unknown. The
disruption of red pulp and white pulp associated with fibrosis,
which occurs around day 14, is reflected in the decrease in the
numbers of B cells and CD41 and CD81 T cells. There is a
marked increase in the proportion of cells that are latently
infected, although these appear to be cleared as normal. Both
these events are mediated by CD81 T cells, as the changes are
completely reversed in CD81 T-cell-depleted mice. Depletion
of CD41 T cells also reversed the gross pathological changes
and the virological changes, although minor changes could be
observed histologically. These results suggest that CD81 T
cells are the major mediators of the damage, but they may
require help in some form from CD41 T cells.
The mechanism by which CD81 T cells mediate the effects is
at present unknown. In the absence of the IFN-g receptor,
CD81 T cells may produce a factor or factors which are re-
sponsible for the splenic damage and the high latency load.
The production of these factors may be controlled in wild-type
mice by ligation of the IFN-g receptor. Thus, IFN-g may have
a direct effect on CD81 T-cell activity in the spleen. Alterna-
tively, the IFN-g R may act as a receptor for another cytokine
molecule, either a cellular cytokine, the synthesis of which is
upregulated by the virus, or a virus-encoded cytokine. It is clear
that IL-15 utilizes the IL-2 receptor molecule (5), and such
dual usage may occur for other receptors. No MHV68-en-
coded cytokine has yet been detected, but cytokine analogs
have been found to be encoded by other gammaherpesviruses,
including Epstein-Barr virus, herpesvirus saimiri, equine her-
pesvirus 2, and equine herpesvirus 5 (13, 22, 25). Such a cyto-
kine might downregulate the virus latency and regulate patho-
logical mechanisms following MHV68 infection.
Production of damage-mediating factors by CD81 T cells
might be regulated by cytokines or factors produced by other
cell types. Clearly CD41 T cells are involved in such a process.
A second IFN-g receptor has been reported on human mac-
rophages adhered to polystyrene in vitro (9). This is a low-
affinity receptor but might be active if high levels of IFN-g are
present. The role of macrophages in the changes in IFN-g
R2/2 spleens remains to be investigated.
The identity of the factor or factors which are responsible for
the splenic destruction is at present unknown. Changes in
splenic architecture have been observed in normal mice
treated with high doses of recombinant IL-12. These mice
exhibited a poorly discernible white pulp and also changes in
the red pulp. Infection with lymphocytic choriomeningitis vi-
rus, but not murine cytomegalovirus, led to the appearance of
necrotic lesions in the white pulp of IL-12-treated mice, al-
though in these cases the splenic architecture was maintained
(15). The mechanism of the IL-12-mediated toxicity involves
induction of tumor necrosis factor alpha (TNF-a) and results
from an increased sensitivity of splenocytes to TNF-a-medi-
ated killing. Thus, T-cell populations undergoing activation
and proliferation in response to viral infection were targeted
for death (16). The operation of this pathway in MHV68-
infected IFN-g R2/2 mice would require a mechanism for
inducing large amounts of IL-12 in the absence of induction of
IL-12 by IFN-g. Such induction could, however, occur if an
alternative IFN-g receptor was present on macrophages. It is
also possible that TNF-a levels are elevated independently of
IL-12 in the MHV68-infected IFN-g R2/2 mice. These mice
do not, however, exhibit other signs of TNF-a-mediated dam-
age (thymic atrophy and wasting), and a different mechanism
may be operating in these mice.
Little is known about the mechanisms which control the
proportion of latently infected B cells in MHV68-infected
mice. The IFN-g R2/2 mice clearly have a higher transient
load of latently infected cells than wild-type mice despite the
decreased number of B cells. CD41 T-cell-depleted mice do
not show the transient high levels of latently infected cells that
are present in immunocompetent mice (4, 23) and CD81 T-
cell-depleted mice develop a higher latency load by day 12 than
wild-type mice (8). Interestingly, the CD81 T-cell-depleted
IFN-g R2/2 mice have a latency load similar to that of wild-
type mice. At present it is not known whether cells become
latently infected in the spleen or in peripheral tissues. It is
conceivable that latently infected cells traffic to the spleen and
proliferate there, and in wild-type mice the proliferation is
controlled by direct anti-proliferative action of IFN-g. In the
IFN-g R2/2 mice there may be an uncontrolled proliferation
which precedes the downregulation of latently infected cells by
other IFN-g-independent mechanisms. It is also clear that
there is a higher level of virus replication in the spleens of
IFN-g R2/2 mice, and this may be in some way related to the
high latency load.
The data presented here show that there are drastic conse-
quences of the lack of the IFN-g receptor in MHV68-infected
mice. While it is possible that the pathological and virological
observations are due simply to a lack of functional IFN-g, it is
also possible that the mechanisms are more complex and that
TABLE 2. Effect of T-cell subset depletion on MHV68-induced














Wild type Splenomegaly 195 (64) 8.9 (2.8) 794 (184)
Wild type, CD8
depleted
Splenomegaly 191 (84) 11.2 (3.0) 340 (309)
IFN-g R2/2 Pale, fibrous 91 (8) 1.7 (0.2) 11,292 (7,039)
IFN-g R2/2,
CD8 depleted
Splenomegaly 145 (80) 8.8 (2.9) 351 (238)
CD41
Wild type Splenomegaly 229 (20) 13.9 (0.1) 486 (112)
Wild type, CD4
depleted
Normal 82 (21) 3.81 (1.0) 47 (45)
IFN-g R2/2 Pale, fibrous 88 (16) 3.03 (1.5) 9,657 (4,621)
IFN-g R2/2,
CD4 depleted
Normal 82 (28) 3.47 (1.6) 264 (133)
a Mice were depleted of specific T-cell subsets by intravenous injection of
depleting anti-CD8 or anti-CD4 monoclonal antibodies 2 days prior to infection
and 2 days postinfection and by intraperitoneal injection 9 days postinfection.
Spleens were harvested 17 days postinfection.
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it is the lack of the receptor itself which is responsible. These
mechanisms are currently under investigation.
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